Molecular screening and docking analysis of LMTK3and AKT1 combined inhibitors

Loubna Allam1,2, Ghrifi Fatima1, Lakhlili Wiame1

  • 1Biotechnology Laboratory (Medbiotech), BioInova Research center, Rabat Medical and Pharmacy School, MedBiotech Center,Mohammed V University in Rabat, Rabat, 10000, Morroco.

Bioinformation
|June 22, 2019
PubMed

Insights

Computer-aided drug design identified novel AKT1 and LMTK3 inhibitors to combat drug resistance. These compounds show potential as therapeutic candidates for pain management and cancer treatment.

Area of Science:

  • Biochemistry
  • Pharmacology
  • Computational Chemistry

Background:

  • Abnormal activation of the AKT/mTOR signaling pathway and LMTK3 overexpression are key drivers of drug resistance.
  • Computer-aided drug design (CADD) offers a strategic approach to discover novel inhibitors for overcoming drug resistance.

Purpose of the Study:

  • To identify potential drug candidates targeting AKT1 and LMTK3 proteins implicated in drug resistance using CADD.
  • To develop a Quantitative Structure-Activity Relationship (QSAR) model for designing more potent AKT1 inhibitors.

Main Methods:

  • Virtual screening and molecular docking of AKT1 and LMTK3 proteins were performed using the Dockblaster server.
  • A QSAR study utilizing the Partial Least Squares method was conducted for AKT1 inhibitors.
  • ADME (Absorption, Distribution, Metabolism, and Excretion) predictions were performed to assess pharmacological activity.

Main Results:

  • Five compounds were identified as competitive AKT1-ATP inhibitors with enhanced biological activity (R2=0.8062, q2=0.6995).
  • Five compounds were selected as competitive ATP-inhibitors of LMTK3.
  • One identified compound inhibits both AKT1 and LMTK3 and is used in pain therapy.

Conclusions:

  • The study successfully identified potential drug candidates for AKT1 and LMTK3 using CADD and QSAR.
  • The identified inhibitors demonstrate promising pharmacological activity and potential for drug development.
  • These findings offer new therapeutic avenues for managing drug resistance and pain.

Related Concept Videos

Eukaryotic Transcription Inhibitors01:52

Eukaryotic Transcription Inhibitors

Certain biochemical processes, such as embryonic development and cell growth regulation, depend on the repression of specific genes. DNA binding proteins known as eukaryotic transcription inhibitors regulate the repression of gene expression in eukaryotes. The presence of these inhibitors at the required location and time in the cell is triggered by the presence of hormones and additional signals from other cells.
Eukaryotic transcription inhibitors usually contain two distinct domains, a...
10.9K
Molecular Orbital Theory I02:35

Molecular Orbital Theory I

Overview of Molecular Orbital Theory
47.1K
Kinetic Molecular Theory: Molecular Velocities, Temperature, and Kinetic Energy03:07

Kinetic Molecular Theory: Molecular Velocities, Temperature, and Kinetic Energy

The kinetic molecular theory qualitatively explains the behaviors described by the various gas laws. The postulates of this theory may be applied in a more quantitative fashion to derive these individual laws.
29.7K
Molecular Models02:00

Molecular Models

Physical models representing molecular architectures of chemical compounds play essential roles in understanding chemistry. The use of molecular models makes it easier to visualize the structures and shapes of atoms and molecules.
43.6K
Molecular Compounds: Formulas and Nomenclature03:10

Molecular Compounds: Formulas and Nomenclature

Molecular compounds or covalent compounds result when atoms share electrons to form covalent bonds. Since there is no electron transfer, molecular compounds do not contain ions; instead, they consist of discrete, neutral molecules. 
55.4K
Molecular Orbital Theory II03:51

Molecular Orbital Theory II

Molecular Orbital Energy Diagrams
27.0K